Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

Characteristic

Total

(N = 810)

Female sex – no. (%)

305 (38)

Age – years

 

   Mean (SD)

69 (10)

Patients fulfilling inclusion criteria – no. (%)

 

   Recent creatinine >1.5 mg/dL

148 (18)

   Diabetes mellitus

458 (57)

   Heart failure

105 (13)

   Shock

2 (0.2)

   Aged >70 years

458 (57)

History of hypertension – no. (%)

659 (81.4)

Serum creatinine – mg/dL

 

   Median (IQR)

1.1 (0.5)

Estimated creatinine clearance* – mL/kg/min

 

   Median (IQR)

60 (38)

  1. SD, standard deviation; IQR, interquartile range.
  2. * Creatinine clearance estimated by the Cockcroft-Gault formula.